CEACAM6 serves as a biomarker for leptomeningeal metastasis in lung adenocarcinoma.
Xueying WangXuemei TangJiahui GuZiwei SunShengrui YangYuan MuMing GuanKun ChenWei LiuHaoyu RuanJian XuPublished in: Cancer medicine (2022)
CEACAM6 may serve as a potential biomarker in diagnosing LUAD-LM.
Keyphrases